is ozempic glp 1 GLP-1 access a problem for people with eating disorders Five Unexpected New Uses for
Description
It drastically reduces the medication's effectiveness

5- other GLP-1 trials in Parkinsons have been statistically negative or the results unclear, 6- the study was conducted in only very early Parkinsons cases, 7- the data, if replicable, may not be generalizable to all GLP-1 agonist drugs or to all subtypes of Parkinsons, and 8- the drug Lixisenatide requires a DAILY injection

Notably, two oral GLP-1s (Wegovy and Foundayo) and an injectable high-dose version of Wegovy are now approved for weight loss

[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Samhani C, Guerci B, Larose C
:max_bytes(150000):strip_icc()/Health-GettyImages-2112991930-7aba42b37c8641d3a76cb03100b26dda.jpg)